Antiviral Drug News and Research

RSS

FDA approves Energex Systems non-drug therapy for HIV research

Energex Systems, Inc. announced today that it has been granted approval from the Federal Food and Drug Administration (FDA) to utilize its experimental HemoModulation therapy in a clinical trial of HIV infected patients. The purpose of the study will be to demonstrate safety and monitor viral load changes in patients who are not yet eligible for antiviral drug therapy.

14 Jul 2008

Researches identify herpesvirus proteins that target key cellular processes

A study published July 11th in the open-access journal PLoS Pathogens suggests that herpesviruses use multiple strategies to manipulate important components of the host cell nuclear environment during infection.

13 Jul 2008

Enzymes are the way to a virus' 'heart'

The arrival of bluetongue virus (BTV) in the UK last year posed a major threat to the economy and the increasing temperatures of our changing climate mean it is here to stay.

9 Jul 2008

European businesses not properly advised on how to prepare for flu pandemic

A new report entitled Business Continuity Planning and Pandemic Influenza in Europe, published by the London School of Hygiene & Tropical Medicine (LSHTM), has found huge gaps and differences across Europe in the level of advice given to businesses to prepare for a possible influenza pandemic.

11 Jun 2008

Quick responses to influenza outbreaks reduces illness and death

Influenza outbreaks were shorter and resulted in fewer cases and fewer deaths at long-term care facilities that started residents on preventive antiviral medications within five days of the first case, compared to those that started later, according to a new study in the July 1 issue of Clinical Infectious Diseases, currently available online.

11 Jun 2008

Investigational smallpox drug may treat adenovirus infections in humans

Scientists at Saint Louis University have made two key discoveries that could lead to the first-ever human testing of a drug to target the adenovirus, which causes a number of severe upper-respiratory infections and is one of many viruses that causes the common cold.

19 May 2008

Bird flu pandemic risk just as real and probably growing

Experts are warning that the risk of a human bird flu pandemic remains just as real and is in fact probably growing.

8 May 2008

Experts review influenza pandemic preparedness guidance

With the onging threat of a global influenza pandemic demanding continued vigilance, 120 influenza and planning experts from WHO Member States, research institutions and UN agencies around the globe are meeting in Geneva this week to review the current WHO pandemic preparedness guidance. Key scientific and situational developments make the review particularly important. WHO will release the revised guidance later this year.

7 May 2008

Researchers highlight distinct subtypes of myalgic encephalomyelitis

Researchers have identified distinct subtypes of myalgic encephalomyelitis (ME/CFS - also referred to as chronic fatigue syndrome) and there is renewed hope that treatments are available for this debilitating neurological illness.

7 May 2008

Bird flu pandemic risk just as real and probably growing

Experts are warning that the risk of a human bird flu pandemic remains just as real and is in fact probably growing.

7 May 2008

Better understanding of immune response to HIV infection

The "exhaustion" of immune cells that target HIV appears to result from chronic exposure to the virus, specifically exposure to the particular protein segments targeted by the pathogen-killing HIV-specific CD8 T cells.

6 May 2008

Drug candidate to treat smallpox scaled up by new partnership

Two American companies are teaming up for second-round test-phase production of a FDA-designated "fast track" drug candidate to treat smallpox, a deadly virus that is feared to be able to reach people through acts of bio-warfare or bio-terrorism.

5 May 2008

New weapon against respiratory syncytial virus

University of Texas Medical Branch at Galveston researchers have achieved promising results with a potential new weapon against respiratory syncytial virus, the most common cause of infant hospitalization in the United States.

5 May 2008

Stanford researchers synthesize new agents to flush HIV out of hiding

Any hunter will tell you that when your quarry goes into hiding, you have to flush it out to get a good shot at it. Such is the case with HIV, the virus that causes AIDS.

1 May 2008

Chinese authorities again accused of concealing outbreak of deadly virus

As the number of people in China affected by a deadly intestinal virus continues to rise, Chinese authorities have been accused of trying conceal the outbreak

1 May 2008

Human protein may offer novel target for blocking HIV infection

A research group supported by the National Institutes of Health (NIH) has uncovered a new route for attacking the human immunodeficiency virus (HIV) that may offer a way to circumvent problems with drug resistance. In findings published today in the online edition of the Proceedings of the National Academy of Sciences, the researchers report that they have blocked HIV infection in the test tube by inactivating a human protein expressed in key immune cells.

29 Apr 2008

Enterovirus 71 in Chinese province kills 20 children

A virus in China has which has killed 20 children and made 1,179 others ill is causing alarm.

29 Apr 2008

New route discovered for attacking the human immunodeficiency virus

28 Apr 2008

Purdue's new vaccine under development may provide protection against highly pathogenic bird flu

A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice.

17 Apr 2008

Shutting down schools in the event of a bird flu pandemic could prevent up to one in seven cases

Closing schools in the event of a flu pandemic could slow the spread of the virus and prevent up to one in seven cases, according to a new study published today in the journal Nature.

10 Apr 2008